The influence of body weight on the pharmacokinetics of mefloquine [1]

British Journal of Clinical Pharmacology

Volumn 53, Issue 3, 2002, Pages 337-338

  Simpson, J A ^a,b,c   Aarons, L ^d   Price, R ^b,e   White, N J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e SHOKLO MALARIA RESEARCH UNIT   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; MEFLOQUINE;

BODY WEIGHT; COMBINATION CHEMOTHERAPY; COMPARTMENT MODEL; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; HUMAN; LETTER; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; THAILAND;

ANTIMALARIALS; BODY WEIGHT; HUMANS; MALARIA; MEFLOQUINE; MODELS, BIOLOGICAL; THAILAND;

EID: 0036122031     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01561.x     Document Type: Letter

References (5)

1. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria
2. Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria
3. Nonlinear mixed effects models for repeated measures data
4. Quantification of Fansimef components (mefloquine+sulfadoxine+pyrimethamine) in human plasma by two high performance liquid chromatographic methods
5. Clinical pharmacokinetics of mefloquine